002923SZSE

Announcement Regarding Shareholder Equity Change Touching a 1% Integer Multiple

Rundu Co., Ltd.··4 pages

✨ AI Summary

This announcement from Zhuhai Rundu Pharmaceutical Co., Ltd. details a shareholding change by major shareholders. Li Xi and Chen Xinmin's combined stake decreased from 53.78% to 52.96% due to a 0.81% reduction by Li Xi. This change triggers a 1% integer multiple notification. The change does not affect control or governance.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002923

Securities Abbreviation: Rundu Shares

Announcement Number: 2026-061

Zhuhai Rundu Pharmaceutical Co., Ltd.

Announcement Regarding Shareholder Equity Change Touching a 1% Integer Multiple

The Company's controlling shareholder, Mr. Li Xi, and his concerted party, Mr. Chen Xinmin, guarantee that the information provided to the Company is true, accurate, and complete, without any false records, misleading statements, or significant omissions.

The Company and all members of the Board of Directors guarantee that the content of this announcement is consistent with the information provided by the information disclosure obligors.

Special Reminder:

  1. Mr. Li Xi, a shareholder holding more than 5% of the Company's shares, reduced his holdings of the Company's unrestricted tradable shares by 2,720,000 shares through block trading from August 4, 2026, to August 5, 2026. This reduction accounts for 0.81% of the Company's total share capital.

  2. Before this equity change, the Company's controlling shareholder, Mr. Li Xi, and his concerted party, Mr. Chen Xinmin, collectively held 180,091,374 shares, representing 53.78% of the total share capital. After this change, Mr. Li Xi and Mr. Chen Xinmin collectively hold 177,371,374 shares, representing 52.96% of the total share capital. This equity change caused the proportion of shares held by Mr. Li Xi and Mr. Chen Xinmin collectively to touch an integer multiple of 1%.

  3. This equity change will not result in a change of the Company's controlling shareholder or actual controller, nor will it have a significant impact on the Company's corporate governance structure and future sustainable operations.

I. Basic Information on the Equity Change

Zhuhai Rundu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "Rundu Shares") disclosed the "Announcement on the Pre-disclosure of Share Reduction by Shareholders Holding More Than 5% of Shares" (Announcement Number: 2026-038) on May 7, 2026. Mr. Li Xi, one of the Company's controlling shareholders and actual controllers, planned to reduce his holdings of the Company's shares by a total of no more than 10,046,797 shares within three months after fifteen trading days from the date of the announcement (i.e., from May 28, 2026, to August 27, 2026) through centralized bidding transactions and block trading, which would not exceed 3.00% of the Company's total share capital. Of this, the planned reduction through centralized bidding transactions would not exceed 3,348,932 shares (accounting for 1% of the total share capital), and the reduction through block trading would not exceed 6,697,865 shares (accounting for 2% of the total share capital).

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.